EA200901369A1 - Применение ивабрадина в качестве диагностического средства в методе коронарной ангиографии путем многослойной компьютерной томографии - Google Patents
Применение ивабрадина в качестве диагностического средства в методе коронарной ангиографии путем многослойной компьютерной томографииInfo
- Publication number
- EA200901369A1 EA200901369A1 EA200901369A EA200901369A EA200901369A1 EA 200901369 A1 EA200901369 A1 EA 200901369A1 EA 200901369 A EA200901369 A EA 200901369A EA 200901369 A EA200901369 A EA 200901369A EA 200901369 A1 EA200901369 A1 EA 200901369A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- ivabradin
- coronary angiography
- application
- computer tomography
- diagnostic means
- Prior art date
Links
- 238000002591 computed tomography Methods 0.000 title abstract 2
- 238000002586 coronary angiography Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- ACRHBAYQBXXRTO-OAQYLSRUSA-N ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 abstract 1
- 229960003825 ivabradine Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Abstract
Применение ивабрадина, или 3-{3-[{[(7S)-3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил]метил}(метил)амино]пропил}-7,8-диметокси-1,3,4,5-тетрагидро-2H-3-бензазепин-2-она, его солей присоединения с фармацевтически приемлемыми кислотами и их гидратов, в качестве диагностического средства в методе коронарной ангиографии путем многослойной компьютерной томографии.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0806225A FR2938194B1 (fr) | 2008-11-07 | 2008-11-07 | Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200901369A1 true EA200901369A1 (ru) | 2011-06-30 |
| EA017641B1 EA017641B1 (ru) | 2013-02-28 |
Family
ID=40677692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200901369A EA017641B1 (ru) | 2008-11-07 | 2009-11-06 | Применение ивабрадина в качестве диагностического средства в методе коронарной ангиографии путем многослойной компьютерной томографии |
Country Status (44)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2800442C (en) * | 2010-06-14 | 2018-05-22 | Ratiopharm Gmbh | Ivabradine-containing pharmaceutical composition with modified release |
| CN106580873A (zh) * | 2016-11-08 | 2017-04-26 | 北京万全德众医药生物技术有限公司 | 伊伐布雷定或其可药用盐口服溶液及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
| ATE533509T1 (de) | 2003-08-08 | 2011-12-15 | Ono Pharmaceutical Co | Herzverlangsamender arzneistoff mit beta-blockern mit kurzzeitwirkung als wirkstoff |
| FR2882553B1 (fr) * | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| FR2894826B1 (fr) * | 2005-12-21 | 2010-10-22 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent |
| FR2911279B1 (fr) * | 2007-01-11 | 2009-03-06 | Servier Lab | Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale |
-
2008
- 2008-11-07 FR FR0806225A patent/FR2938194B1/fr not_active Expired - Fee Related
-
2009
- 2009-10-27 UY UY0001032202A patent/UY32202A/es not_active Application Discontinuation
- 2009-10-27 SG SG200907132-5A patent/SG161186A1/en unknown
- 2009-10-27 PE PE2009001203A patent/PE20100744A1/es not_active Application Discontinuation
- 2009-10-29 IL IL201815A patent/IL201815A/en not_active IP Right Cessation
- 2009-10-29 MY MYPI20094554A patent/MY145991A/en unknown
- 2009-10-30 CO CO09123025A patent/CO6230160A1/es not_active Application Discontinuation
- 2009-10-31 SA SA109300653A patent/SA109300653B1/ar unknown
- 2009-11-02 AU AU2009235984A patent/AU2009235984B2/en not_active Ceased
- 2009-11-02 MA MA32319A patent/MA31418B1/fr unknown
- 2009-11-02 JO JO2009405A patent/JO2838B1/en active
- 2009-11-04 ZA ZA200907753A patent/ZA200907753B/en unknown
- 2009-11-04 KR KR1020090105856A patent/KR101168484B1/ko not_active Expired - Fee Related
- 2009-11-04 UA UAA200911196A patent/UA101612C2/ru unknown
- 2009-11-04 NI NI200900195A patent/NI200900195A/es unknown
- 2009-11-04 CR CR11094A patent/CR11094A/es unknown
- 2009-11-04 SV SV2009003401A patent/SV2009003401A/es active IP Right Grant
- 2009-11-05 GT GT200900288A patent/GT200900288A/es unknown
- 2009-11-05 US US12/590,269 patent/US20100119459A1/en not_active Abandoned
- 2009-11-05 CA CA2685303A patent/CA2685303C/fr not_active Expired - Fee Related
- 2009-11-05 CL CL2009002032A patent/CL2009002032A1/es unknown
- 2009-11-05 AP AP2009005035A patent/AP2635A/xx active
- 2009-11-05 EC EC2009009715A patent/ECSP099715A/es unknown
- 2009-11-05 NZ NZ580984A patent/NZ580984A/en not_active IP Right Cessation
- 2009-11-05 GE GEAP200911545A patent/GEP20135729B/en unknown
- 2009-11-06 RS RS20110378A patent/RS51948B/en unknown
- 2009-11-06 BR BRPI0904376-4A patent/BRPI0904376A2/pt not_active Application Discontinuation
- 2009-11-06 PL PL09290841T patent/PL2184065T3/pl unknown
- 2009-11-06 PA PA20098847801A patent/PA8847801A1/es unknown
- 2009-11-06 AR ARP090104293A patent/AR074294A1/es unknown
- 2009-11-06 SI SI200930057T patent/SI2184065T1/sl unknown
- 2009-11-06 AT AT09290841T patent/ATE516806T1/de active
- 2009-11-06 ME MEP-2009-328A patent/ME00953B/me unknown
- 2009-11-06 TW TW098137810A patent/TWI426923B/zh not_active IP Right Cessation
- 2009-11-06 MX MX2009012014A patent/MX2009012014A/es active IP Right Grant
- 2009-11-06 ES ES09290841T patent/ES2370145T3/es active Active
- 2009-11-06 DK DK09290841.7T patent/DK2184065T3/da active
- 2009-11-06 CN CN200910220828A patent/CN101732734A/zh active Pending
- 2009-11-06 WO PCT/FR2009/001282 patent/WO2010052394A1/fr active Application Filing
- 2009-11-06 EA EA200901369A patent/EA017641B1/ru not_active IP Right Cessation
- 2009-11-06 JP JP2009254783A patent/JP2010111673A/ja active Pending
- 2009-11-06 EP EP09290841A patent/EP2184065B1/fr active Active
-
2011
- 2011-09-22 HR HR20110684T patent/HRP20110684T1/hr unknown
- 2011-09-27 CY CY20111100927T patent/CY1112037T1/el unknown
-
2012
- 2012-11-02 JP JP2012242503A patent/JP6029935B2/ja active Active
-
2015
- 2015-10-21 JP JP2015206934A patent/JP2016040304A/ja active Pending
-
2016
- 2016-08-25 US US15/247,037 patent/US20160361444A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG158799A1 (en) | New process for the preparation of functionalised benzocyclobutenes, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| ZA200905566B (en) | Process for the resolution of enantiomers of (3,4-dimethoxy-bicyclo [4.2.0] octa-1,3,5-trien-7-YL) nitrile and application in the synthesis of ivabradine | |
| FR2937324B1 (fr) | Procede de preparation d'un materiau composite a base de nanotubes, notamment de carbone | |
| CY1116438T1 (el) | ΧΡΗΣΗ ΤΟΥ ΣΥΝΔΥΑΣΜΟΥ ΕΝΟΣ ΑΝΑΣΤΟΛΕΑ ΤΟΥ ΦΛΕΒΟΚΟΜΒΙΚΟΥ ΡΕΥΜΑΤΟΣ If ΚΑΙ ΕΝΟΣ ΑΝΑΣΤΟΛΕΑ ΤΟΥ ΕΝΖΥΜΟΥ ΜΕΤΑΤΡΟΠΗΣ ΤΗΣ ΑΓΓΕΙΟΤΑΣΙΝΗΣ ΓΙΑ ΤΗ ΘΕΡΑΠΕΙΑ ΤΗΣ ΚΑΡΔΙΑΚΗΣ ΑΝΕΠΑΡΚΕΙΑΣ | |
| EA200901369A1 (ru) | Применение ивабрадина в качестве диагностического средства в методе коронарной ангиографии путем многослойной компьютерной томографии | |
| MY148650A (en) | Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction | |
| GEP20135970B (en) | New method of synthesis of ivabradine and pharmaceutically acceptable acid-additive salts thereof | |
| SG116574A1 (en) | New process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and applicationin the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid. | |
| CY1116500T1 (el) | Μεθοδος ενζυματικης συνθεσης toy (7s)-1-(3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριεν-7-υλ)-ν-μεθυλομεθαναμινης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων αυτης | |
| CL2012003136A1 (es) | Procedimiento de sintesis de 3-{3-[{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metil)amino]propil}-7,8-dimetoxi-1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona (ivabradina). | |
| CU20090186A7 (es) | Composición inyectable de ivabradina | |
| GEP20156235B (en) | Process for enzymatic synthesis of (7s)-3,4-dimethoxy-bicyclo-[4.2.0]octa-1,3,5-triene-7- carboxylic acid or esters thereof, and application in synthesis of ivabradine and salts thereof | |
| TN2009000455A1 (fr) | Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe | |
| TH125503A (th) | การใช้ของไอวาบราดีนในฐานะสารที่เกี่ยวกับการวินิจฉัยโรคในวิธีการของโคโรนารี แองจิโอกราฟฟี โดยมัลติสไลซ์ คอมพิวเทด โทโมกราฟฟี | |
| TH104268A (th) | สารต้าน n,n-ไดซับสทิทยูเทด อะมิโนอัลคิลไบฟีนิล ของตัวรับ โพรสตาแกลนด์ d2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |